The higher levels of DYRK1A expression found in the brains of people with AD and Pick's disease and the overlap with hyperphosphorylated tau suggest that the kinase is contributing to tau disease pathogenesis (Ferrer et al., 2005). Here, MAPT is linked to Alzheimer disease.